Drug management in the elderly adult with chronic kidney disease: A review for the primary care physician

Mayo Clinic Proceedings

Volumn 90, Issue 5, 2015, Pages 633-645

  Ponticelli, Claudio ^a   Sala, Gabriele ^a   Glassock, Richard J ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LITHIUM; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERUM ALBUMIN; VITAMIN;

CHRONIC KIDNEY DISEASE; DRUG ABSORPTION; DRUG CHOICE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INTERACTION; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG UNDERDOSING; GENERAL PRACTITIONER; GERIATRIC ASSESSMENT; GERIATRIC CARE; GLOMERULUS FILTRATION RATE; HUMAN; INAPPROPRIATE PRESCRIBING; KIDNEY DISEASE; LEAN BODY WEIGHT; LIVER BLOOD FLOW; MEDICATION COMPLIANCE; PATIENT SELECTION; PHARMACEUTICAL CARE; PHARMACODYNAMICS; PHARMACOLOGICAL PARAMETERS; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; AGED; CHRONIC KIDNEY FAILURE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; KIDNEY; PATHOPHYSIOLOGY; POLYPHARMACY; PRIMARY HEALTH CARE;

AGED; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; KIDNEY; PHYSICIANS, PRIMARY CARE; POLYPHARMACY; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84929024629     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.01.016     Document Type: Review

References (98)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Inter 3 Supp 2013 1 150
2. P.P. Reese, A.R. Cappola, and J. Shults Physical performance and frailty in chronic kidney disease Am J Nephrol 38 4 2013 307 315
3. J.L. Vincent Relevance of albumin in modern critical care medicine Best Pract Res Clin Anaesthesiol 23 2 2009 183 191
4. A. Bhutto, and J.E. Morley The clinical significance of gastrointestinal changes with aging Curr Opin Clin Nutr Metab Care 11 5 2008 651 660
5. R.P. Hull, and D.J. Goldsmith Nephrotic syndrome in adults BMJ 336 7654 2008 1185 1189
6. A.A. Mangoni, and S.H. Jackson Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications Br J Clin Pharmacol 57 1 2004 6 14
7. S. Shi, and U. Klotz Age-related changes in pharmacokinetics Curr Drug Metab 12 7 2011 601 610
8. C.E. Staatz, and S.E. Tett Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update Arch Toxicol 88 7 2014 1351 1389
9. F. Keller, M. Maiga, H.H. Neumayer, H. Lode, and A. Distler Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease Eur J Drug Metab Pharmacokinet 9 3 1984 275 282
10. K. Tajiri, and Y. Shimizu Liver physiology and liver diseases in the elderly World J Gastroenterol 19 46 2013 8459 8467
11. K. Turnheim Drug therapy in the elderly Exp Gerontol 39 11-12 2004 1731 1738
12. S.F. Zhou Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I Clin Pharmacokinet 48 11 2009 689 723
13. C.F. Samer, K.I. Lorenzini, V. Rollason, Y. Daali, and J.A. Desmeules Applications of CYP450 testing in the clinical setting Mol Diagn Ther 17 3 2013 165 184
14. A.W. Dreisbach, and J.J. Lertora The effect of chronic renal failure on drug metabolism and transport Expert Opin Drug Metab Toxicol 4 8 2008 1065 1074
15. R.D. Lindeman, J. Tobin, and N.W. Shock Longitudinal studies on the rate of decline in renal function with age J Am Geriatr Soc 33 4 1985 278 285
16. R.J. Glassock, and C. Winearls Ageing and the glomerular filtration rate: truths and consequences Trans Am Clin Climatol Assoc 120 2009 419 428
17. G.R. Matzke, G.R. Aronoff, and A.J. Atkinson Jr. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 80 11 2011 1122 1137
18. R.J. Glassock, and C.G. Winearls eGFR: Readjusting its rating Clin J Am Soc Nephrol 4 5 2009 867 869
19. A. Farag, A.X. Garg, L. Li, and A.K. Jain Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis Am J Kidney Dis 63 3 2014 422 428
20. A. Corsonello, C. Pedone, and F. Lattanzio Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: Implications for drug dosing Age Ageing 40 5 2011 583 589
21. A. Corsonello, C. Pedone, and R.A. Incalzi Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions Curr Med Chem 17 6 2010 571 584
22. M. Gianni, J. Bosch, and J. Pogue Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients Eur Heart J 28 11 2007 1382 1388
23. K.N. Chaudhry, P. Chavez, J. Gasowski, T. Grodzicki, and F.H. Messerli Hypertension in the elderly: some practical considerations Cleve Clin J Med 79 10 2012 694 704
24. E.J. Eichhorn, and M. Gheorghiade Digoxin Prog Cardiovasc Dis 44 4 2002 251 266
25. A.S. Mansfield, and Q. Qian 71-year-old man with chronic kidney failure and sudden change of mental status Mayo Clin Proc 84 11 2009 e5 e8
26. H.J.M. Beijer, and C.J. de Blaey Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies Pharm World Sci 24 2 2002 46 54
27. T.G. Cantú, E.F. Ellerbeck, S.W. Yun, S.D. Castine, and D.M. Kornhauser Drug prescribing for patients with changing renal function Am J Hosp Pharm 49 12 1992 2944 2948
28. F.S. Sharif-Askari, S.A. Syed Sulaiman, N. Saheb Sharif-Askari, and A. Al Sayed Hussain Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease PLoS One 9 4 2014 e95991
29. H. Son, D. Lee, L.A. Lim, S.B. Jang, H. Roh, and K. Park Development of a pharmacokinetic interaction model for co-administration of simvastatin and amlodipine Drug Metab Pharmacokinet 29 2 2014 120 128
30. L. Vidal, M. Shavit, A. Fraser, M. Paul, and L. Leibovici Systematic comparison of four sources of drug information regarding adjustment of dose for renal function BMJ 331 7511 2005 263
31. R.K. Verbeeck, and F.T. Musuamba Pharmacokinetics and dosage adjustment in patients with renal dysfunction Eur J Clin Pharmacol 65 8 2009 757 773
32. American Geriatrics Society 2012 Beers Criteria Update Expert Panel American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults J Am Geriatr Soc 60 4 2012 616 631
33. P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, and D. O'Mahony STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): consensus validation Int J Clin Pharmacol Ther 46 2 2008 72 83
34. S.M. Patterson, C.A. Cadogan, and N. Kerse Interventions to improve the appropriate use of polypharmacy for older people Cochrane Database Syst Rev 10 2014 CD008165
35. P. Susantitaphong, K. Sewaralthahab, E.M. Balk, S. Eiam-ong, N.E. Madias, and B.L. Jaber Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis Am J Hypertens 26 3 2013 424 441
36. P. Rossignol, D. Dobre, and J.J.V. McMurray Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF) Circ Heart Fail 7 1 2014 51 58
37. Z. Harel, S. Harel, P.S. Shah, R. Wald, J. Perl, and C.M. Bell Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review Am J Med 126 3 2013 264.e9 264.e24
38. K.S. Kamel, and M. Schreiber Asking the question again: are cation exchange resins effective for the treatment of hyperkalemia? Nephrol Dial Transplant 27 12 2012 4294 4297
39. M. Kosiborod, H.S. Rasmussen, and P. Lavin Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial JAMA 312 21 2014 2223 2233
40. D.L. Paterson, J.M. Robson, and M.M. Wagener Risk factors for toxicity in elderly patients given aminoglycosides once daily J Gen Intern Med 13 11 1998 735 739
41. T.P. Lodise, N. Patel, B.M. Lomaestro, K.A. Rodvold, and G.L. Drusano Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients Clin Infect Dis 49 4 2009 507 514
42. R. Stahlmann, and H. Lode Safety considerations of fluoroquinolones in the elderly: an update Drugs Aging 27 3 2010 193 209
43. C.C. Hung, M.C. Kuo, J.M. Chang, and H.C. Chen Fluoroquinolone-induced acute interstitial nephritis in immunocompromised patients: two case reports Nephrol Dial Transplant 21 1 2006 237 238
44. C.A. Gentry, and A.T. Nguyen An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications Ann Pharmacother 47 12 2013 1618 1626
45. T. Antoniou, T. Gomes, D.N. Juurlink, M.R. Loutfy, R.H. Glazier, and M.M. Mamdani Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study Arch Intern Med 170 12 2010 1045 1049
46. T. Antoniou, T. Gomes, M.M. Mamdani, and D.N. Juurlink Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study Br J Clin Pharmacol 71 4 2011 544 549
47. A.J. Wright, T. Gomes, M.M. Mamdani, J.R. Horn, and D.N. Juurlink The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers CMAJ 183 3 2011 303 307
48. L.S. Rallidis, K. Fountoulaki, and M. Anastasiou-Nana Man ageing the underestimated risk of statin-associated myopathy Int J Cardiol 159 3 2012 169 176
49. A.L. Chan, M.T. Wang, C.Y. Su, and F.H. Tsai Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study Eur J Clin Pharmacol 65 12 2009 1237 1243
50. R.I. Shorr, W.A. Ray, J.R. Daugherty, and M.R. Griffin Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease Arch Intern Med 153 14 1993 1665 1670
51. S.V. Brodsky, T. Nadasdy, and B.H. Rovin Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate Kidney Int 80 2 2011 181 189
52. S.R. Taksande, and E.M. Worcester Calcium supplementation in chronic kidney disease Expert Opin Drug Saf 13 9 2014 1175 1185
53. S. Rej, N. Herrmann, and K. Shulman The effects of lithium on renal function in older adults - a systematic review J Geriatr Psychiatry Neurol 25 1 2012 51 61
54. A. Bocchetta, R. Ardau, and P. Carta Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study BMC Med 11 2013 33
55. M. Zaidan, F. Stucker, and B. Stengel Increased risk of solid renal tumors in lithium-treated patients Kidney Int 86 1 2014 184 190
56. B. Hanchard, C. Boulouffe, and D. Vanpee Sulfonylurea-induced hypoglycaemia: use of octreotide Acta Clin Belg 64 1 2009 56 58
57. R.G. Brodows Benefits and risks with glyburide and glipizide in elderly NIDDM patients Diabetes Care 15 1 1992 75 80
58. A.M.E. Stades, J.T. Heikens, D.W. Erkelens, F. Holleman, and J.B. Hoekstra Metformin and lactic acidosis: cause or coincidence? A review of case reports J Intern Med 255 2 2004 179 187
59. D.M. Nathan, J.B. Buse, M.B. Davidson American Diabetes Association; European Association for Study of Diabetes Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 1 2009 193 203
60. L.K. Elmore, S. Baggett, J.A. Kyle, and J.W. Skelley A review of the efficacy and safety of canagliflozin in elderly patients with type 2 diabetes Consult Pharm 29 5 2014 335 346
61. M.E. Tinetti, L. Han, and D.S. Lee Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults JAMA Intern Med 174 4 2014 588 595
62. C. Andersson, D. Shilane, and A.S. Go β-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease J Am Coll Cardiol 64 3 2014 247 252
63. L.M. Kuyper, and N.A. Khan Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis Can J Cardiol 30 5, suppl 2014 S47 S53
64. W.B. Stason, C.H. Schmid, and D. Niedzwiecki Safety of nifedipine in patients with hypertension: a meta-analysis [published correction appears in Hypertension. 1999;34(3):531] Hypertension 30 1, pt 1 1997 7 14
65. S.Y. Jung, N.K. Choi, and J.Y. Kim Short-acting nifedipine and risk of stroke in elderly hypertensive patients Neurology 77 13 2011 1229 1234
66. K. Miyagawa, Y. Dohi, and A. Nakazawa Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension: a randomized crossover trial between benidipine and amlodipine Clin Exp Hypertens 32 1 2010 1 7
67. D. Fliser, M. Schröter, M. Neubeck, and E. Ritz Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure Kidney Int 46 2 1994 482 488
68. C.R. Harper, and T.A. Jacobson Managing dyslipidemia in chronic kidney disease J Am Coll Cardiol 51 25 2008 2375 2384
69. T. Takenaka, H. Takane, T. Kikuta, Y. Watanabe, and H. Suzuki Statin improves flow-mediated vasodilation in chronic kidney diseases Int J Hypertens 2013 2013 876865
70. C. Baigent, M.J. Landray, C. Reith SHARP Investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
71. S.C. Palmer, S.D. Navaneethan, and J.C. Craig HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Cochrane Database Syst Rev 5 2014 CD007784
72. N. Sattar, D. Preiss, and H.M. Murray Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 9716 2010 735 742
73. U. Bilge, G. Sahin, I. Unluoglu, M. Ipek, M. Durdu, and A. Keskin Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy Ren Fail 35 6 2013 906 910
74. V. Schneider, L.E. Lévesque, B. Zhang, T. Hutchinson, and J.M. Brophy Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis Am J Epidemiol 164 9 2006 881 889
75. R.R. Townsend, and D.L. Cohen Use of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of acute kidney injury Evid Based Med 18 6 2013 232 233
76. H. Kikuchi, M. Aoyagi, and K. Nagahama Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch Intern Med 53 11 2014 1131 1135
77. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons Pharmacological management of persistent pain in older persons J Am Geriatr Soc 57 8 2009 1331 1346
78. R. Robson, J.M. Cecka, G. Opelz, M. Budde, and S. Sacks Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil Am J Transplant 5 12 2005 2954 2960
79. G. Feutren, and M.J. Mihatsch Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases N Engl J Med 326 25 1992 1654 1660
80. D.R.J. Kuypers Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions Drugs Aging 26 9 2009 715 737
81. B.J. Nankivell, and K.M. Murali Images in clinical medicine: renal failure from vitamin C after transplantation N Engl J Med 358 4 2008 e4
82. E. Ingelsson, and L. Lind Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly Diabetes Care 32 4 2009 733 735
83. A. Henze, S.K. Frey, and J. Raila Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels Diabetes 57 12 2008 3323 3326
84. P. Ravani, F. Malberti, and G. Tripepi Vitamin D levels and patient outcome in chronic kidney disease Kidney Int 75 1 2009 88 95
85. E.W. Yu, S.R. Bauer, P.A. Bain, and D.C. Bauer Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies Am J Med 124 6 2011 519 526
86. D.M. McCarthy Adverse effects of proton pump inhibitor drugs: clues and conclusions Curr Opin Gastroenterol 26 6 2010 624 631
87. A. Corsonello, M. Maggio, and S. Fusco Proton pump inhibitors and functional decline in older adults discharged from acute care hospitals J Am Geriatr Soc 62 6 2014 1110 1115
88. C.P. Luk, R. Parsons, Y.P. Lee, and J.D. Hughes Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Ann Pharmacother 47 6 2013 773 780
89. D.G. Klepser, D.S. Collier, and G.L. Cochran Proton pump inhibitors and acute kidney injury: a nested case-control study BMC Nephrol 14 2013 150
90. G. Liamis, H. Milionis, and M. Elisaf A review of drug-induced hyponatremia Am J Kidney Dis 52 1 2008 144 153
91. D. Kirby, and D. Ames Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients Int J Geriatr Psychiatry 16 5 2001 484 493
92. D. Zalai, L. Szeifert, and M. Novak Psychological distress and depression in patients with chronic kidney disease Semin Dial 25 4 2012 428 438
93. A. Harugeri, J. Joseph, G. Parthasarathi, M. Ramesh, and S. Guido Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals J Postgrad Med 56 3 2010 186 191
94. E.S. Schaeffner, N. Ebert, and P. Delanaye Two novel equations to estimate kidney function in persons aged 70 years or older Ann Intern Med 157 7 2012 471 481
95. M.W. Doak, A.C. Nixon, D.J. Lupton, and W.S. Waring Self-poisoning in older adults: patterns of drug ingestion and clinical outcomes Age Ageing 38 4 2009 407 411
96. P.J. Barry, P. Gallagher, C. Ryan, and D. O'mahony START (screening tool to alert doctors to the right treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients Age Ageing 36 6 2007 632 638
97. A.J. Claxton, J. Cramer, and C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 8 2001 1296 1310
98. D.M. Qato, G.C. Alexander, R.M. Conti, M. Johnson, P. Schumm, and S.T. Lindau Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States JAMA 300 24 2008 2867 2878